Genmab A/S(GMAB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GMAB Genmab A/S

盘前交易 11-22 09:01:01 EST

20.47

+0.02

+0.10%

盘前20.70

+0.23+1.12%

08:33 EST

最高20.62	最低20.34	成交量151.26万
今开20.53	昨收20.45	日振幅1.37%
总市值130.01亿	流通市值128.63亿	总股本6.35亿
成交额3,101万	换手率0.24%	流通股本6.28亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"GMAB","market":"US","secType":"STK","nameCN":"Genmab A/S","latestPrice":20.47,"timestamp":1732222800000,"preClose":20.45,"halted":0,"volume":1512565,"hourTrading":{"tag":"盘前","latestPrice":20.7,"preClose":20.47,"latestTime":"08:33 EST","volume":6165,"amount":126103.01589,"timestamp":1732282387692},"delay":0,"floatShares":628365159,"shares":635136220,"eps":1.080027,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.02,"latestTime":"11-22 09:01:01 EST","open":20.53,"high":20.62,"low":20.34,"amount":31008812.215345,"amplitude":0.013692,"askPrice":20.67,"askSize":1200,"bidPrice":20.65,"bidSize":200,"shortable":3,"etf":0,"ttmEps":1.080027,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732285800000},"adr":0,"listingDate":1563422400000,"adjPreClose":20.47,"adrRate":0.1,"preHourTrading":{"tag":"盘前","latestPrice":20.7,"preClose":20.47,"latestTime":"08:33 EST","volume":6165,"amount":126103.01589,"timestamp":1732282387692},"postHourTrading":{"tag":"盘后","latestPrice":20.52,"preClose":20.47,"latestTime":"19:21 EST","volume":6782,"amount":138885.51,"timestamp":1732234873929},"volumeRatio":1.028741410323856,"impliedVol":0.5325,"impliedVolPercentile":0.7729},"requestUrl":"/m/hq/s/GMAB","defaultTab":"news","newsList":[{"id":"2483638585","title":"Genmab As2024财年第三财季实现净利润1.86亿美元，同比减少40.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483638585","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483638585?lang=zh_cn&edition=full","pubTime":"2024-11-15 00:01","pubTimestamp":1731600070,"startTime":"0","endTime":"0","summary":"11月15日，Genmab As公布财报，公告显示公司2024财年第三财季净利润为1.86亿美元，同比减少40.19%；其中营业收入为8.16亿美元，同比增加17.92%，每股基本收益为0.29美元。从资产负债表来看，Genmab As总负债11.58亿美元，其中短期债务13.62百万美元，资产负债比为5.13，流动比率为5.18。机构评级：截至2024年11月15日，当前有20家机构对Genmab As目标价做出预测，其中目标均价为36.89美元，其中最低目标价为26.18美元，最高目标价为50.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115000126a238003b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115000126a238003b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GMAB"],"gpt_icon":0},{"id":"2469112856","title":"Genmab As盘中异动 股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469112856","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469112856?lang=zh_cn&edition=full","pubTime":"2024-09-23 21:32","pubTimestamp":1727098320,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日21时32分，Genmab As股票出现波动，股价大幅下跌5.19%。Genmab As股票所在的生物技术行业中，整体跌幅为0.26%。Genmab As公司简介：Genmab AS是一家总部位于哥本哈根的生物技术公司，专门从事用于治疗癌症的抗体疗法。Genmab的专有抗体技术是DuoBody、HexaBody、DuoHexaBody和HexElect。强生公司与Genmab公司合作开发了Darzalex，该药物被视为多发性骨髓瘤的标准治疗药物，是Genmab公司的主要产品。Genmab公司还拥有多个针对其他肿瘤适应症的候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923213200ab655c41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923213200ab655c41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GMAB","BK4139"],"gpt_icon":0},{"id":"2460795735","title":"Genmab As2024财年第二财季实现净利润2.03亿美元，同比增加2.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460795735","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460795735?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:01","pubTimestamp":1723910469,"startTime":"0","endTime":"0","summary":"8月18日，Genmab As公布财报，公告显示公司2024财年第二财季净利润为2.03亿美元，同比增加2.53%；其中营业收入为7.80亿美元，同比增加27.24%，每股基本收益为0.32美元。从资产负债表来看，Genmab As总负债10.99亿美元，其中短期债务13.51百万美元，资产负债比为5.06，流动比率为5.03。机构评级：截至2024年8月18日，当前有19家机构对Genmab As目标价做出预测，其中目标均价为39.11美元，其中最低目标价为29.00美元，最高目标价为53.00美元。Genmab有几种针对其他肿瘤适应症的候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800014095a163a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800014095a163a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GMAB"],"gpt_icon":0},{"id":"2457565777","title":"明晟公司MSCI北欧国家指数跌2.8%，报374.83点，创2月5日以来收盘新低。保健板块领跌，成分股全线溃败。个股中，Genmab A/S跌7.","url":"https://stock-news.laohu8.com/highlight/detail?id=2457565777","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457565777?lang=zh_cn&edition=full","pubTime":"2024-08-05 23:36","pubTimestamp":1722872201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/us-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/us-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["GMAB","LU2210149790.SGD","LU1267930730.SGD","BK4139","LU0511384066.AUD","LU0672654240.SGD","LU0289961442.SGD","LU0320765059.SGD","LU0175139822.USD","LU2265009873.SGD","GNMSF","LU0109391861.USD","BK4585","LU0289739343.SGD","LU2210150020.SGD","BK4588","LU0289960550.SGD","LU2095319765.USD","MSCI","LU0708995401.HKD","LU1804176565.USD","BK4112"],"gpt_icon":0},{"id":"2446799582","title":"HC Wainwright &amp; Co.：重申Genmab(GMAB.US)评级，由买入调整至买入评级, 目标价由50.","url":"https://stock-news.laohu8.com/highlight/detail?id=2446799582","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446799582?lang=zh_cn&edition=full","pubTime":"2024-06-27 18:30","pubTimestamp":1719484241,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","GMAB"],"gpt_icon":0},{"id":"2446589177","title":"Genmab A/S：BTIG将目标价从46美元上调至47美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2446589177","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446589177?lang=zh_cn&edition=full","pubTime":"2024-06-27 17:38","pubTimestamp":1719481109,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GMAB","BK4139","GNMSF"],"gpt_icon":0},{"id":"2440547009","title":"美国研究综述-霍尼韦尔国际公司、Stericycle、目标公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2440547009","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440547009?lang=zh_cn&edition=full","pubTime":"2024-06-04 15:29","pubTimestamp":1717486180,"startTime":"0","endTime":"0","summary":"    路透6月4日 - 华尔街证券分析师周二调整了对霍尼韦尔国际公司、Stericycle 和目标公司等几家美国上市公司的评级和目标价。要闻             * Brixmor Property Group Inc   ：高盛将该公司列入其在美上市公司信用评级名单              * 霍尼韦尔国际公司  ：加拿大皇家银行将目标价从222美元下调至218美元              * 西蒙地产集团  ：高盛将其股票从美国定罪名单中删除              * Stericycle Inc   ：加拿大皇家银行将其评级从 \"跑赢大盘 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823414478.USD","BWMN","EQT","GPCR","SPG","GMAB","EW","LU2286300806.USD","ARWR","TGT","IE00BMG7P587.USD","SRCL","BK4088","GTLB","QCOM","BK4082","HHH","S","LU1621767810.EUR","BK4539","LU1621767737.EUR","BK4080","HON","BK4154","BRX","IE00BMG7P694.USD","SRE","CMCO","LU1621768115.EUR","SG9999014013.SGD","CLSK","ENPH","FWONK","RIOT","TOL","BK4155","SGC","HUM","ZS","BK4187","SO","BK4532","TER","BA","AGIO","MARA","LU1267930227.SGD","FSLR"],"gpt_icon":0},{"id":"2440470047","title":"美国研究综述-霍尼韦尔国际公司、Stericycle、目标公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2440470047","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440470047?lang=zh_cn&edition=full","pubTime":"2024-06-04 15:29","pubTimestamp":1717486180,"startTime":"0","endTime":"0","summary":"    路透6月4日 - 华尔街证券分析师周二调整了对霍尼韦尔国际公司、Stericycle 和目标公司等几家美国上市公司的评级和目标价。要闻             * Brixmor Property Group Inc   ：高盛将该公司列入其在美上市公司信用评级名单              * 霍尼韦尔国际公司  ：加拿大皇家银行将目标价从222美元下调至218美元              * 西蒙地产集团  ：高盛将其股票从美国定罪名单中删除              * Stericycle Inc   ：加拿大皇家银行将其评级从 \"跑赢大盘 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823414478.USD","BWMN","EQT","GPCR","SPG","GMAB","EW","LU2286300806.USD","ARWR","TGT","IE00BMG7P587.USD","SRCL","BK4088","GTLB","QCOM","BK4082","HHH","S","LU1621767810.EUR","BK4539","LU1621767737.EUR","BK4080","HON","BK4154","BRX","IE00BMG7P694.USD","SRE","CMCO","LU1621768115.EUR","SG9999014013.SGD","CLSK","ENPH","FWONK","RIOT","TOL","BK4155","SGC","HUM","ZS","BK4187","SO","BK4532","TER","BA","AGIO","MARA","LU1267930227.SGD","FSLR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.genmab.com","stockEarnings":[{"period":"1week","weight":-0.0335},{"period":"1month","weight":-0.101},{"period":"3month","weight":-0.2513},{"period":"6month","weight":-0.2689},{"period":"1year","weight":-0.3512},{"period":"ytd","weight":-0.3571}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Genmab A/S于1998年6月11日注册成立。他们是一家国际生物技术公司，专门从事抗体治疗癌症和其他疾病的治疗。他们的核心目的是通过创造和开发创新的抗体产品来改善患者的生活。公司的愿景是通过在2025年推出自己的专利产品来改变癌症治疗方法，并推进其分化和耐受良好的抗体管道。他们正在建设和扩展他们的后期开发和商业能力，以便他们将来可以将他们的专有产品推向市场。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.066457},{"month":2,"riseRate":0.2,"avgChangeRate":-0.043592},{"month":3,"riseRate":0.6,"avgChangeRate":0.012635},{"month":4,"riseRate":0.6,"avgChangeRate":0.05109},{"month":5,"riseRate":0.6,"avgChangeRate":0.037692},{"month":6,"riseRate":0.6,"avgChangeRate":0.010399},{"month":7,"riseRate":1,"avgChangeRate":0.084534},{"month":8,"riseRate":0.5,"avgChangeRate":0.0292},{"month":9,"riseRate":0,"avgChangeRate":-0.068463},{"month":10,"riseRate":0.5,"avgChangeRate":-0.010217},{"month":11,"riseRate":0.666667,"avgChangeRate":0.053293},{"month":12,"riseRate":0.6,"avgChangeRate":-0.009591}],"exchange":"NASDAQ","name":"Genmab A/S","nameEN":"Genmab A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Genmab A/S(GMAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Genmab A/S(GMAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Genmab A/S,GMAB,Genmab A/S股票,Genmab A/S股票老虎,Genmab A/S股票老虎国际,Genmab A/S行情,Genmab A/S股票行情,Genmab A/S股价,Genmab A/S股市,Genmab A/S股票价格,Genmab A/S股票交易,Genmab A/S股票购买,Genmab A/S股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Genmab A/S(GMAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Genmab A/S(GMAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}